Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo
Official title: Effectiveness of Combining Micro Needling With 5 Fluorouracil Versus Potent Topical Steroids; in Treating Limited Vitiligo- Randomised Controlled Study
Status: Recruiting now
Description:
The goal of this clinical trial is to learn how well 5 fluorouracil (5FU) with micro-needling works to treat limited vitiligo as compared to strong steroid applied on skin. It will also learn about the safety of both these treatments. The main questions it aims to answer are: • How well does 5FU with microneedling work to treat vitiligo by returning pigmentation in vitiligo patches as compared to steroid? • What is participant's satisfaction when treated with 5FU with microneedling as compared to steroid? • What skin problems do participants have when treated with FU with microneedling and steroid? Researchers will compare 5FU with microneedling to steroid application to see how well both work to return pigment in vitiligo patches. Participants will be divided into two groups. For Group A, 5 FU will be rubbed and absorbed on the vitiligo patch after micro-needling every 2 weeks. For group B, topical 0.05% clobetasol propionate ointment will be applied twice a day on the vitiligo patches for 12 weeks. Vitiligo patches will be assessed at the start of trial and then after 12 weeks of treatment.
Phase: Early Phase 1.
What is being studied: drugs — Microneedling with 5-fluorouracil, Topical application of 0.05% Clobetasol propionate.
Who can take part: ages 4 Years to 70 Years, 40 participants planned.
Enrollment status: the registry has not updated this study since its planned completion date, so its current status is unclear. The study started 08 August 2025 and was due to finish 01 February 2026.
Source: ClinicalTrials.gov, NCT07398807 (https://clinicaltrials.gov/study/NCT07398807).
Start date: August 08, 2025
Completion date: February 01, 2026
Organizer: Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan
Link: https://clinicaltrials.gov/study/NCT07398807
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- How can I cure vitiligo?
Right now, there is no universal "cure," but we have entered a new era of treatment. Today, managing vitiligo isn’t just about "hiding" it; it’s about sophisticated science that...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.